This genetic medicine stock soared more than 50% on Industry First
Hours after Alex Ovechkin became the first NHL player to score 800 goals with a single team, Avidity Biosciences (RNA) – Get a free report announced a first in its industry. The pre-commercial drug developer has provided positive results in a Phase 1 clinical trial evaluating AOC-1001 in myotonic dystrophy type 1 (DM1). The drug …
This genetic medicine stock soared more than 50% on Industry First Read More »